Hälsa och välfärd

The success of this project may enable the development of actionable, personalised interventional strategies to slow down ageing and prevent/delay age-predisposed diseases.

This project will identify people at-risk of dementia who may benefit from preventive interventions and investigate biological mechanisms for the development and prevention of dementia including between country comparisons of the Nordics and Japan.

This project envisions the development of refined diagnostic approaches that identify Osteoarthritis subtypes and indicators of its progression, at earlier stages of the disease.

Prescribing medicine today is based on a One Size Fits All principle. We have, however, a need for more personalized solutions in several critical therapy areas. The recent development within genomics and diagnostic field has enabled development of new innovative medicinal products relying on a combination of diagnostic tools and personalized dose. This approach is paving the way towards future health care system based on personalized medicines. Limited attention has been given to the personalized end-product requirements for optimal therapeutic performance. Complex dosing regimens will require advances in product design to enable precise administration of the most appropriate dose. Innovations in pharmaceutical product design are required to alleviate potential problems.

Acute myelogenous leukemia (AML) is the most coomon acute leukemia in adults with and annual incidence of 4 cases per 100 000 inhabitans. Median age at diagnosis is 70 years. For patients below 55 years, the prognosis has gradually improved the last decades, but elderly patiens still do poorly; the survival being around 30% with no improvement of outome after standard chemotherapy treatment.

Crohn's disease is a chronic inflammatory bowel disease. The biological drug Remicade is used in patients with Crohn's disease when normal treatment is inadequate. About one in three of the patients starting treatment with Remicade have sustained good effect over several years. However, serious side effects such as; infections, allergic reactions and concerns about long-term safety, with suspected increased risk of developing cancer, necessitate exploring strategies for when and in which patients to stop (discontinue) treatment again.

Scientific content: The main focus of the current course will be to give an overview of Nordic health research based on register data and introduce a wide range of epidemiologic methods relevant for this type of data. Important health registers, and other Nordic registers relevant for register research will be presented.

The workplace, along with the school, primary care and hospital, has been established as one of the priority settings for health promotion. Work-related factors may influence the health of employees in various ways and, in the long run, contribute to healthy ageing.